Literature DB >> 1614460

[Endocrinologic disorders in deletion of chromosome 18].

W Andler1, A Heüveldop, T Polichronidou.   

Abstract

Patients suffering from deletions of chromosome 18 (p-, q-) show regularly short stature. Endocrinological investigations were performed to prove if short stature is due to pituitary insufficiency. In three female patients with deletions of chromosome 18 and retarded bone age serum growth hormone was investigated after insulin induced hypoglycemia, after glucagon-propranolol and after stimulation with growth hormone releasing hormone. Thyroid function, gonadal function and adrenal function were investigated too. All three patients showed growth hormone deficiency. In one patient there were found in addition hypothyroidism and gonadotrophine deficiency as well. In conclusion growth failure in some patients with deletions of chromosome 18 seems to due to pituitary insufficiency. In these patients treatment with recombinant growth hormone may increase growth velocity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1614460

Source DB:  PubMed          Journal:  Monatsschr Kinderheilkd        ISSN: 0026-9298            Impact factor:   0.323


  2 in total

1.  18q deletion syndrome - A case report.

Authors:  Magdalena Budisteanu; Aurora Arghir; Sorina Mihaela Chirieac; Andreea Tutulan-Cunita; Agripina Lungeanu
Journal:  Maedica (Buchar)       Date:  2010-04

2.  Immune Dysregulation in Patients With Chromosome 18q Deletions-Searching for Putative Loci for Autoimmunity and Immunodeficiency.

Authors:  Anna Hogendorf; Maciej Zieliński; Maria Constantinou; Robert Śmigiel; Jolanta Wierzba; Krystyna Wyka; Anna Wędrychowicz; Anna Jakubiuk-Tomaszuk; Edyta Budzynska; Malgorzata Piotrowicz; Beata S Lipska-Ziętkiewicz; Ewa Kaczorowska; Agata Cieślikowska; Anna Kutkowska-Kaźmierczak; Jolanta Fijak-Moskal; Monika Kugaudo; Małgorzata Kosińska-Urbańska; Agnieszka Szadkowska; Maciej Borowiec; Maciej Niedźwiecki; Piotr Trzonkowski; Wojciech Młynarski
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.